Traders positioned to make money from falls in the share price have accumulated the paper profits since the stock’s closing ...

The FDA is due to make its final decision by 12 January ... gene therapies approved in Europe have already found making a profit difficult. Earlier this year uniQure withdrew Glybera, the world ...

Traders positioned to make money from falls in the share price have accumulated the paper profits since the stock’s closing high on December 17, according to data provider S3 Partners.